Dark

Check out our API

CSBR
Champions Oncology, Inc.
stock NASDAQ

At Close

Dec 29, 2025 3:59:30 PM EST

6.90USD-1.146%(-0.08)7,361

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-6.98)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 20, 2022

08:44AM EST Champions Oncology Announces Partnership With Fannin Innovation To Jointly Develop Therapeutic Raptamer Drug Conjugates Benzinga

Jan 4, 2022

08:37AM EST Champions Oncology Announces Partnership With Alloy Therapeutics To Develop Therapeutic Monoclonal Antibodies For Use In ADC Programs Benzinga

Dec 14, 2021

10:08AM EST Looking Into Champions Oncology's Return On Capital Employed Benzinga

Dec 13, 2021

04:07PM EST Champions Oncology Q2 EPS $0.03, Sales $11.80M Beat $11.55M Estimate Benzinga

03:56AM EST Earnings Scheduled For December 13, 2021 Benzinga

Oct 20, 2021

10:28AM EDT Champions Oncology Highlights Opening Of Its European Lab In Italy Benzinga

Sep 13, 2021

04:01PM EDT Champions Oncology Q1 EPS $0.01, Inline, Sales $11.30M Beat $10.97M Estimate Benzinga

03:58AM EDT Earnings Scheduled For September 13, 2021 Benzinga

Jul 22, 2021

08:23AM EDT Champions Oncology Q1 Revenue $10.6M, Up 21% YoY Benzinga

04:02AM EDT Earnings Scheduled For July 22, 2021 Benzinga

Jun 15, 2021

09:04AM EDT Champions Oncology And BGI Americas Announce Partnership To Provide Mass Spectrometry Proteomics, Metabolomics, And Multi-Omic Data Analysis Solutions Benzinga

Mar 17, 2021

07:43AM EDT The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes Benzinga

Mar 16, 2021

08:17AM EDT The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study Benzinga

Mar 15, 2021

09:05AM EDT Roth Capital Maintains Buy on Champions Oncology, Raises Price Target to $16 Benzinga

Mar 12, 2021

07:36AM EST The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs Benzinga

Mar 11, 2021

04:01PM EST Champions Oncology Q3 Adj. EPS $0.07 Beats $0.01 Estimate, Sales $10.80M Beat $10.14M Estimate Benzinga

03:35AM EST Earnings Scheduled For March 11, 2021 Benzinga

Jan 19, 2021

09:14AM EST Champions Oncology Announces Partnership With Code Ocean To Expand Functionality Of Lumin Bioinformatics Benzinga

Dec 15, 2020

09:55AM EST Champions Oncology shares were trading higher after the company reported better-than-expected Q2 sales results. Benzinga

Dec 14, 2020

04:01PM EST Champions Oncology Q2 EPS $0.01 Down From $0.03 YoY, Sales $10.10M Beat $9.38M Estimate Benzinga

05:03AM EST Earnings Scheduled For December 14, 2020 Benzinga

Dec 13, 2020

04:27PM EST The Week Ahead In Biotech: 2 IPOs Plus FDA Decisions On Moderna's COVID Vaccine And Drugs From Amgen, MacroGenics Benzinga

Nov 18, 2020

07:30AM EST The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted Benzinga

Nov 17, 2020

08:32AM EST The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration Benzinga

Nov 16, 2020

04:51PM EST Champions Oncology Announces Launch Of Lumin Bioinformatics, Its 'Oncology Data-Driven SaaS Program' Benzinga

Nov 11, 2020

09:07AM EST Champions Oncology Launches Autologous Tumor Infiltrating Lymphocyte Ex Vivo Platform Benzinga

Sep 14, 2020

04:24PM EDT Recap: Champions Oncology Q1 Earnings Benzinga

04:01PM EDT Champions Oncology Q1 EPS $0.02, Inline, Sales $9.50M Beat $8.71M Estimate Benzinga

04:05AM EDT Earnings Scheduled For September 14, 2020 Benzinga

Jul 27, 2020

04:26PM EDT Recap: Champions Oncology Q4 Earnings Benzinga

04:09PM EDT Champions Oncology Q4 Sales $8.80M Beat $8.29M Estimate Benzinga

04:01AM EDT Earnings Scheduled For July 27, 2020 Benzinga

Share